Back to search

Article

Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasis

2023-07-25

Abstract excerpt

The presence of cell surface protein CD47 allows cancer cells to evade innate and adaptive immune surveillance resulting in metastatic spread. CD47 binds to and activates SIRPα on the surface of myeloid cells, inhibiting their phagocytic activity. On the other hand, CD47 binds the matricellular protein Thrombospondin-1, limiting T-cell activation. Thus, blocking CD47 is a potential therapeutic strategy for prevent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8f6102e-b2bc-56c9-aa41-cda1f3c1c30c
DOI
10.1101/2023.07.25.550566
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anti-CD47 immunotherapy as a therapeutic strategy for the treatment of breast cancer brain metastasisDOI 10.1101/2023.07.25.550566
Select a neighboring publication to make it the new centre.